Walmart has become the latest store to halt sales of the popular heartburn treatment Zantac after health regulators warned about a potentially dangerous contaminant in the drug. The nation's largest ...
The popular heartburn med Zantac officially exited U.S. shelves last April after FDA probes into an impurity believed to cause cancer. For Sanofi and other companies battling lawsuits from the saga, ...
GSK Concealed Risk Associated With Discontinued Heart Burn Drug Zantac, Whistleblower Lawsuit Claims
GSK Plc (NYSE:GSK) has been reportedly sued by an independent Connecticut laboratory, Valisure, accusing the pharmaceutical giant of defrauding the U.S. government and taxpayers by concealing cancer ...
Sanofi SASNY2.43%increase; green up pointing triangle swung to a loss in the fourth quarter as the recall of heartburn drug Zantac over cancer concerns offset strong sales of newer treatments. The ...
British drugs firm GSK has been accused of burying a report said to prove a link between its medication Zantac and cancer, a new lawsuit has claimed. A pension fund has filed a class action against ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback